- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03526120
Pistachio Intake, Satiety and Body Weight Control in Healthy Adult Women (APIS)
Acute Satiety and Energy Compensation After Consumption of a Pistachio Snack and Longer Term Consequences on Satiety, Anthropometry, and Body Composition After a Nutritional Intervention With Daily Consumption of the Pistachio Snack
Study Overview
Detailed Description
The expected endpoint is to demonstrate that the daily consumption of a snack of pistachios by healthy women, as recommended in the next National Program for Nutrition and Health (program PNNS, France), elicits adequate satiety and does not induce weight gain but rather improves diet quality, body composition and body fat mass distribution (less abdominal fat).
The study will be a 16 weeks randomized controlled open trial, single-center, including two parallel groups of 30 female participants (block randomization stratified on habitual energy intake and initial body weight according to the consort-statement checklist).
The main working hypothesis is a demonstration of the "non inferiority" of the effects of the pistachio intervention on body weight versus no snack consumption. The investigators hypothesize that there will be no significant difference in body weight change due to pistachios consumption. The two-sided 95% confidence interval on the intra-patient difference (before minus after the pistachio intervention) will be provided through the appropriate contrasts.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhône
-
Givors, Rhône, France, F-69700
- Recruiting
- CreaBio Rhône-Alpes
-
Contact:
- Marc Fantino, MD, PhD, Pr
- Phone Number: +33 481 653 365
- Email: marc.fantino@creabio-ra.com
-
Principal Investigator:
- Marc Fantino, MD, PhD, Pr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy women;
- Age: lower age limit 18 years, upper age limit: 50 years (included);
- Body Mass Index: lower limit 19 kg/m²; upper limit 29.9 kg/m²; weight stable within ± 2 kg in the last 3 months;
- Habitual energy intake, as indicated by an initial intake report (diary method, three days) within the 95% confidence interval (CI) of the habitual energy intake of a similar population (as provided by internal reference data collected by CREABio-RA from previous studies in similar conditions);
- Participant not pregnant, not presently breast feeding or having breastfed in the last 3 months, and not planning to become pregnant during the study (negative pregnancy test at inclusion or morning of V1);
- Pre-menopausal participant on effective contraception since at least 3 months (regular 28-day cycle) and who agree to continue their contraception throughout the study;
- Participant registered with the French Social Security;
- participant having signed informed consent
Exclusion Criteria:
- Subject under legal protection or deprived of liberty by judicial or administrative decision.
- Currently diagnosed somatic pathology;
- On medication affecting metabolism, weight, energy intake, or energy expenditure in the last 6 months;
- Major psychiatric disorder, particularly eating disorders as defined by the DSM-V;
- High level of "Restrained Eating" or "Disinhibition", as revealed by the TFEQ or similar questionnaire;
- Strong initial dislike of nuts, specially pistachios, as revealed by questioning about food habits initial dietary questionnaire;
- Habitual consumption of pistachios as revealed by the 3-d intake report (more than twice a week);
- Participants smoking more than 10 cigarettes per day or planning to stop smoking in the next 3 months;
- Currently pregnant, lactating (as specified in article L1121-5 of the Public Health Code) or less than 6 month post-partum;
- Any kind of food allergy, especially allergies or intolerance to nuts;
- Participant not capable of understanding the constraints of the study, who does not agree to abide, and/or unable to communicate normally with investigators;
- Person currently participating in another clinical study, or having used up her annual entitlement to compensation for participation in biomedical studies (4500 €).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pistachio diet
Incorporates 44 g (1 serving) of pistachios into a daily diet
|
Dailly 44 g unsalted pistachios snack for 12 weeks
|
No Intervention: Control
No pistachio consumption
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight
Time Frame: 12 weeks
|
Body weight in kg
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total daily energy intake
Time Frame: 12 weeks
|
Total daily energy intake in kcal
|
12 weeks
|
Appetite ratings
Time Frame: 12 weeks
|
Appetite ratings measured on visual analogic scalls of 100 mm
|
12 weeks
|
Body weight index
Time Frame: 12 weeks
|
Body weight index in kg/m2
|
12 weeks
|
Body fat mass
Time Frame: 12 weeks
|
Body fat mass in kg
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marc FANTINO, MD, PhD, Pr., CreaBio Rhône-Alpes
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- APIS
- ID RCB : 20107-A031 (Registry Identifier: Agence Nationale de Sécurité du Médicament (ANSM, France))
- APG01-0117 (Other Identifier: CreaBio-RA)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Pistachio
-
Penn State UniversityAmerican Pistachio GrowersCompletedCardiovascular Disease | Type 2 DiabetesUnited States
-
Penn State UniversityCompletedCardiovascular Diseases | Type 2 DiabetesUnited States
-
Virginia Polytechnic Institute and State UniversityRecruitingInflammatory ResponseUnited States
-
University of California, San DiegoAmerican Pistachio GrowersCompleted
-
Tufts UniversityAmerican Pistachio GrowersRecruitingEye Diseases | Macular Degeneration | Retinal Degeneration | Retinal DiseasesUnited States
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompleted
-
California State Polytechnic University, PomonaCalifornia Polytechnic State University-San Luis Obispo; American Pistachio... and other collaboratorsCompleted
-
State University of New York - Upstate Medical...Crouse Hospital; Central New York Community Foundation, Inc.WithdrawnHeart Diseases | PregnancyUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompleted
-
St. Jude Children's Research HospitalNational University, SingaporeCompletedLymphoblastic LymphomaUnited States